Prospective Observational Study to Monitor and Assess the Safety of Amvuttra® [Vutrisiran] in a Real-World Cohort of hATTR Amyloidosis Patients

22/01/2024
07/05/2025
EU PAS number:
EUPAS108904
Study
Ongoing
Documents
Study protocol
No information provided.
Study results
No information provided.
Study report
No information provided.
ENCePP Seal
No information provided.